Fibrocor Therapeutics Announces Partnership with Galapagos NV
Fibrocor Therapeutics and Galapagos NV, a Belgo-Dutch pharmaceutical research company, have announced the formation of a partnership for the development of therapeutics to treat fibrotic diseases of the kidney and other organs.